Leap Therapeutics, Inc. (LPTX)

USD 0.42

(1.23%)

Total Assets Summary of Leap Therapeutics, Inc.

  • Leap Therapeutics, Inc.'s latest annual total assets in 2023 was 72.82 Million USD , up 3.51% from previous year.
  • Leap Therapeutics, Inc.'s latest quarterly total assets in 2024 Q2 was 81.42 Million USD , up 40.48% from previous quarter.
  • Leap Therapeutics, Inc. reported annual total assets of 70.35 Million USD in 2022, down -40.33% from previous year.
  • Leap Therapeutics, Inc. reported annual total assets of 117.91 Million USD in 2021, up 116.86% from previous year.
  • Leap Therapeutics, Inc. reported quarterly total assets of 81.42 Million USD for 2024 Q2, up 40.48% from previous quarter.
  • Leap Therapeutics, Inc. reported quarterly total assets of 72.82 Million USD for 2023 FY, up 3.51% from previous quarter.

Annual Total Assets Chart of Leap Therapeutics, Inc. (2023 - 2012)

Historical Annual Total Assets of Leap Therapeutics, Inc. (2023 - 2012)

Year Total Assets Total Assets Growth
2023 72.82 Million USD 3.51%
2022 70.35 Million USD -40.33%
2021 117.91 Million USD 116.86%
2020 54.37 Million USD 630.01%
2019 7.44 Million USD -60.95%
2018 19.07 Million USD -34.37%
2017 29.06 Million USD 350.09%
2016 6.45 Million USD -77.06%
2015 28.14 Million USD -42.2%
2014 48.69 Million USD 134.83%
2013 20.73 Million USD 17.1%
2012 17.7 Million USD 0.0%

Peer Total Assets Comparison of Leap Therapeutics, Inc.

Name Total Assets Total Assets Difference
Sangamo Therapeutics, Inc. 165.32 Million USD 55.949%
IDEAYA Biosciences, Inc. 649.31 Million USD 88.784%
Eton Pharmaceuticals, Inc. 31.74 Million USD -129.442%
Autolus Therapeutics plc 375.38 Million USD 80.6%
Greenwich LifeSciences, Inc. 6.99 Million USD -941.128%
Enlivex Therapeutics Ltd. 36.83 Million USD -97.727%
Shattuck Labs, Inc. 159.56 Million USD 54.36%
LENZ Therapeutics, Inc. 188.45 Million USD 61.357%
CervoMed Inc. 9.97 Million USD -630.257%
Rocket Pharmaceuticals, Inc. 566.34 Million USD 87.141%
Corbus Pharmaceuticals Holdings, Inc. 28.27 Million USD -157.583%
Aptose Biosciences Inc. 12.92 Million USD -463.55%
Precision BioSciences, Inc. 159.78 Million USD 54.422%
Dyadic International, Inc. 8.21 Million USD -786.031%
TScan Therapeutics, Inc. 272.14 Million USD 73.241%
Intensity Therapeutics, Inc. 17.29 Million USD -321.075%
Nektar Therapeutics 398.03 Million USD 81.704%
CytomX Therapeutics, Inc. 205.15 Million USD 64.502%
VYNE Therapeutics Inc. 97.68 Million USD 25.449%
EyePoint Pharmaceuticals, Inc. 355.18 Million USD 79.497%
Adaptive Biotechnologies Corporation 661.13 Million USD 88.985%
GRI Bio, Inc. 2.95 Million USD -2363.633%
Xenetic Biosciences, Inc. 10.6 Million USD -586.69%
Tenaya Therapeutics, Inc. 170.51 Million USD 57.291%
NeuroSense Therapeutics Ltd. 3.17 Million USD -2192.979%
Psyence Biomedical Ltd. 1.13 Million USD -6332.4%
IGM Biosciences, Inc. 423.41 Million USD 82.8%
INmune Bio, Inc. 57 Million USD -27.761%
Opthea Limited 188.79 Million USD 61.426%
Milestone Pharmaceuticals Inc. 75.22 Million USD 3.192%
Omega Therapeutics, Inc. 204.36 Million USD 64.365%
Verastem, Inc. 149.71 Million USD 51.359%
Abeona Therapeutics Inc. 64 Million USD -13.786%
Pliant Therapeutics, Inc. 512.15 Million USD 85.781%
Tonix Pharmaceuticals Holding Corp. 154.45 Million USD 52.851%
Ligand Pharmaceuticals Incorporated 833.06 Million USD 91.258%
NextCure, Inc. 129.41 Million USD 43.729%
Inhibikase Therapeutics, Inc. 14.5 Million USD -402.011%
Organovo Holdings, Inc. 6.34 Million USD -1047.031%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -1590.216%
Arvinas, Inc. 1.3 Billion USD 94.418%
Ovid Therapeutics Inc. 144.02 Million USD 49.436%
CASI Pharmaceuticals, Inc. 75.26 Million USD 3.246%
Rani Therapeutics Holdings, Inc. 57.91 Million USD -25.742%
Centessa Pharmaceuticals plc 362.96 Million USD 79.936%
Arcturus Therapeutics Holdings Inc. 429.4 Million USD 83.04%
Syros Pharmaceuticals, Inc. 168.17 Million USD 56.697%
Senti Biosciences, Inc. 119.48 Million USD 39.05%
BioRestorative Therapies, Inc. 12.61 Million USD -477.439%
Apollomics, Inc. 55.38 Million USD -31.484%
PureTech Health plc 693.97 Million USD 89.506%
Oncternal Therapeutics, Inc. 36.72 Million USD -98.277%
Barinthus Biotherapeutics plc 214.5 Million USD 66.05%
Kymera Therapeutics, Inc. 575.75 Million USD 87.351%
Synaptogenix, Inc. 31.11 Million USD -134.061%
ChromaDex Corporation 54.96 Million USD -32.496%
Beam Therapeutics Inc. 1.45 Billion USD 95.011%
Monopar Therapeutics Inc. 7.34 Million USD -891.469%
Akebia Therapeutics, Inc. 241.7 Million USD 69.87%
Nurix Therapeutics, Inc. 364.53 Million USD 80.023%
Apellis Pharmaceuticals, Inc. 788.73 Million USD 90.767%
Dermata Therapeutics, Inc. 7.97 Million USD -812.75%
Gritstone bio, Inc. 177.76 Million USD 59.034%
Mesoblast Limited 669.15 Million USD 89.117%
Virpax Pharmaceuticals, Inc. 9.62 Million USD -656.361%
Xeris Biopharma Holdings, Inc. 340.79 Million USD 78.631%
Fate Therapeutics, Inc. 506.21 Million USD 85.614%
MediWound Ltd. 66.45 Million USD -9.579%
BioXcel Therapeutics, Inc. 73.7 Million USD 1.19%
Fortress Biotech, Inc. 167.52 Million USD 56.529%
Fractyl Health, Inc. Common Stock 76.21 Million USD 4.444%
Achilles Therapeutics plc 161.45 Million USD 54.895%
Seres Therapeutics, Inc. 358.6 Million USD 79.692%
Checkpoint Therapeutics, Inc. 5.37 Million USD -1254.128%
Atossa Therapeutics, Inc. 96.25 Million USD 24.339%
Zai Lab Limited 1.03 Billion USD 92.973%
Fresh Tracks Therapeutics, Inc. 11.58 Million USD -528.56%
Lyell Immunopharma, Inc. 750.02 Million USD 90.29%
Vanda Pharmaceuticals Inc. 648.44 Million USD 88.769%
Tarsus Pharmaceuticals, Inc. 266.22 Million USD 72.645%
InMed Pharmaceuticals Inc. 11.82 Million USD -515.972%
FibroGen, Inc. 423.52 Million USD 82.805%
Celcuity Inc. 191.21 Million USD 61.915%
SeaStar Medical Holding Corporation 3.51 Million USD -1973.015%
ContextLogic Inc. 423 Million USD 82.784%
GH Research PLC 226.3 Million USD 67.819%
HOOKIPA Pharma Inc. 161.33 Million USD 54.862%
Cyclacel Pharmaceuticals, Inc. 8.8 Million USD -727.087%
ImmuCell Corporation 43.8 Million USD -66.236%
Amylyx Pharmaceuticals, Inc. 517.45 Million USD 85.926%
Amarin Corporation plc 831.68 Million USD 91.244%
TG Therapeutics, Inc. 329.58 Million USD 77.904%
Aptevo Therapeutics Inc. 24.84 Million USD -193.153%
Jasper Therapeutics, Inc. 95.38 Million USD 23.648%
Foghorn Therapeutics Inc. 285.91 Million USD 74.529%
Y-mAbs Therapeutics, Inc. 127.86 Million USD 43.047%
Aptorum Group Limited 20.64 Million USD -252.833%
Ultragenyx Pharmaceutical Inc. 1.49 Billion USD 95.116%
BioCryst Pharmaceuticals, Inc. 516.96 Million USD 85.913%
Chemomab Therapeutics Ltd. 22.15 Million USD -228.764%
Arrowhead Pharmaceuticals, Inc. 765.55 Million USD 90.487%
TransCode Therapeutics, Inc. 5.16 Million USD -1308.689%
RAPT Therapeutics, Inc. 173.32 Million USD 57.985%
Ardelyx, Inc. 297.57 Million USD 75.528%
Ainos, Inc. 31.84 Million USD -128.709%
Lyra Therapeutics, Inc. 142.6 Million USD 48.931%
Prothena Corporation plc 696.38 Million USD 89.542%
HilleVax, Inc. 344.43 Million USD 78.857%
Adaptimmune Therapeutics plc 282.61 Million USD 74.232%
Celularity Inc. 143.88 Million USD 49.388%
Rallybio Corporation 115.62 Million USD 37.013%
Cue Biopharma, Inc. 61.53 Million USD -18.357%
Omeros Corporation 378.26 Million USD 80.748%
Humacyte, Inc. 128.22 Million USD 43.204%
Immunocore Holdings plc 597 Million USD 87.802%
Cocrystal Pharma, Inc. 31.25 Million USD -132.973%
Blueprint Medicines Corporation 1.04 Billion USD 93.059%
IO Biotech, Inc. 150.71 Million USD 51.681%
MEI Pharma, Inc. 41.37 Million USD -76.012%
GT Biopharma, Inc. 14.1 Million USD -416.16%
Cabaletta Bio, Inc. 253.65 Million USD 71.289%
Summit Therapeutics Inc. 202.94 Million USD 64.117%
Alaunos Therapeutics, Inc. 8.26 Million USD -781.338%
Marinus Pharmaceuticals, Inc. 170.9 Million USD 57.389%
Scholar Rock Holding Corporation 311.03 Million USD 76.586%
Pulmatrix, Inc. 33.95 Million USD -114.456%
Elicio Therapeutics, Inc. 27.14 Million USD -168.272%
X4 Pharmaceuticals, Inc. 147.25 Million USD 50.546%
Vigil Neuroscience, Inc. 140.85 Million USD 48.299%
Acelyrin, Inc. 742.69 Million USD 90.194%
Intellia Therapeutics, Inc. 1.3 Billion USD 94.402%
Cytokinetics, Incorporated 824.31 Million USD 91.165%
Vor Biopharma Inc. 209.82 Million USD 65.293%
Evogene Ltd. 51.1 Million USD -42.512%
Replimune Group, Inc. 487.72 Million USD 85.068%
Applied Therapeutics, Inc. 54.83 Million USD -32.812%
PDS Biotechnology Corporation 59.39 Million USD -22.621%
Hoth Therapeutics, Inc. 9.52 Million USD -664.946%
BridgeBio Pharma, Inc. 546.38 Million USD 86.671%
AEON Biopharma, Inc. 6.84 Million USD -963.915%
BioLineRx Ltd. 63.92 Million USD -13.923%
Galectin Therapeutics Inc. 28.2 Million USD -158.245%
Atai Life Sciences N.V. 293.47 Million USD 75.186%
Aerovate Therapeutics, Inc. 127.41 Million USD 42.846%
VistaGen Therapeutics, Inc. 123.65 Million USD 41.105%
Zentalis Pharmaceuticals, Inc. 562.02 Million USD 87.042%
Sagimet Biosciences Inc. 96.71 Million USD 24.705%
MediciNova, Inc. 66.26 Million USD -9.891%
Praxis Precision Medicines, Inc. 87.94 Million USD 17.195%
MiMedx Group, Inc. 239.04 Million USD 69.535%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -1531.982%
Axsome Therapeutics, Inc. 588.23 Million USD 87.62%
PTC Therapeutics, Inc. 1.9 Billion USD 96.174%
Mereo BioPharma Group plc 66.49 Million USD -9.513%
Syndax Pharmaceuticals, Inc. 612.88 Million USD 88.118%
NRx Pharmaceuticals, Inc. 7.31 Million USD -895.557%
Dyne Therapeutics, Inc. 165.08 Million USD 55.886%
BriaCell Therapeutics Corp. 5.87 Million USD -1140.153%
Allakos Inc. 243.61 Million USD 70.106%
scPharmaceuticals Inc. 94.47 Million USD 22.919%
Fulcrum Therapeutics, Inc. 257.69 Million USD 71.74%
Corcept Therapeutics Incorporated 621.51 Million USD 88.283%
NLS Pharmaceutics AG 1.84 Million USD -3843.647%
Precigen, Inc. 151.04 Million USD 51.785%
XOMA Corporation 234.3 Million USD 68.918%
Kezar Life Sciences, Inc. 221.23 Million USD 67.083%
Incyte Corporation 6.78 Billion USD 98.926%
Alzamend Neuro, Inc. 631.58 Thousand USD -11430.46%
Cara Therapeutics, Inc. 125.84 Million USD 42.131%
Aligos Therapeutics, Inc. 153.9 Million USD 52.681%
Seer, Inc. 436.26 Million USD 83.307%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -284.835%
CRISPR Therapeutics AG 2.22 Billion USD 96.734%
Akero Therapeutics, Inc. 580.27 Million USD 87.45%
Eliem Therapeutics, Inc. 110.46 Million USD 34.077%
EyeGate Pharmaceuticals, Inc. 15.15 Million USD -380.453%
Akari Therapeutics, Plc 4.35 Million USD -1572.216%
Novavax, Inc. 1.85 Billion USD 96.075%
Lexaria Bioscience Corp. 3.08 Million USD -2261.392%
UroGen Pharma Ltd. 178.31 Million USD 59.158%
Sutro Biopharma, Inc. 470.73 Million USD 84.53%
Entera Bio Ltd. 11.76 Million USD -518.997%
Lisata Therapeutics, Inc. 54.69 Million USD -33.15%
Stoke Therapeutics, Inc. 228.34 Million USD 68.107%
Chimerix, Inc. 212.77 Million USD 65.774%
Reneo Pharmaceuticals, Inc. 107.43 Million USD 32.215%
Phathom Pharmaceuticals, Inc. 413.84 Million USD 82.403%
Outlook Therapeutics, Inc. 32.3 Million USD -125.457%
Jazz Pharmaceuticals plc 11.39 Billion USD 99.361%
AnaptysBio, Inc. 452.38 Million USD 83.902%
Aprea Therapeutics, Inc. 22.65 Million USD -221.521%
Portage Biotech Inc. 7.77 Million USD -836.174%
Olema Pharmaceuticals, Inc. 276.94 Million USD 73.704%
PMV Pharmaceuticals, Inc. 252.15 Million USD 71.119%
OKYO Pharma Limited 1.54 Million USD -4625.018%
Qualigen Therapeutics, Inc. 2.03 Million USD -3481.708%
Cadrenal Therapeutics, Inc. Common Stock 8.51 Million USD -754.829%
Processa Pharmaceuticals, Inc. 5.78 Million USD -1158.502%
AbCellera Biologics Inc. 1.48 Billion USD 95.106%
Genprex, Inc. 10.67 Million USD -582.483%
Neumora Therapeutics, Inc. Common Stock 496.19 Million USD 85.323%
NLS Pharmaceutics AG 1.84 Million USD -3843.647%
Virios Therapeutics, Inc. 4.16 Million USD -1648.314%
Daré Bioscience, Inc. 21.28 Million USD -242.187%
Titan Pharmaceuticals, Inc. 8.08 Million USD -800.631%
Bicycle Therapeutics plc 595.34 Million USD 87.768%
Revolution Medicines, Inc. Warrant 2.08 Billion USD 96.513%
Protagonist Therapeutics, Inc. 357.95 Million USD 79.655%
Erasca, Inc. 395.29 Million USD 81.577%
bluebird bio, Inc. 619.16 Million USD 88.238%
Pieris Pharmaceuticals, Inc. 38.68 Million USD -88.276%
BioMarin Pharmaceutical Inc. 6.84 Billion USD 98.936%
DBV Technologies S.A. 182.98 Million USD 60.202%
Fortress Biotech, Inc. 167.52 Million USD 56.529%
Avidity Biosciences, Inc. 628.55 Million USD 88.414%
CorMedix Inc. 82.05 Million USD 11.254%
Travere Therapeutics, Inc. 788.91 Million USD 90.769%
Sensei Biotherapeutics, Inc. 74.37 Million USD 2.083%
Orchestra BioMed Holdings, Inc. 95.21 Million USD 23.513%
Spruce Biosciences, Inc. 103.94 Million USD 29.94%
Celldex Therapeutics, Inc. 465.62 Million USD 84.36%
Cartesian Therapeutics, Inc. 305.05 Million USD 76.127%
Cogent Biosciences, Inc. 313.43 Million USD 76.766%
Onconetix, Inc. 88.82 Million USD 18.01%
Ocuphire Pharma, Inc. 53.94 Million USD -34.991%
Prime Medicine, Inc. 193.85 Million USD 62.432%
Adagene Inc. 115.72 Million USD 37.073%
Inhibrx Biosciences, Inc. 307.89 Million USD 76.347%
GlycoMimetics, Inc. 45.31 Million USD -60.703%
Maravai LifeSciences Holdings, Inc. 1.48 Billion USD 95.104%
Verve Therapeutics, Inc. 752.68 Million USD 90.325%
Voyager Therapeutics, Inc. 351.28 Million USD 79.269%
SciSparc Ltd. 11.18 Million USD -551.27%
Revelation Biosciences, Inc. 12.21 Million USD -496.31%
Minerva Neurosciences, Inc. 56.9 Million USD -27.986%
Astria Therapeutics, Inc. 254.66 Million USD 71.404%
Spero Therapeutics, Inc. 182.39 Million USD 60.072%
Tevogen Bio Holdings Inc. 17.03 Million USD -327.444%
Arcutis Biotherapeutics, Inc. 341.36 Million USD 78.667%
Marker Therapeutics, Inc. 17.12 Million USD -325.196%
Alnylam Pharmaceuticals, Inc. 3.82 Billion USD 98.099%
Artelo Biosciences, Inc. 20.42 Million USD -256.566%
2seventy bio, Inc. 565.42 Million USD 87.12%
ADMA Biologics, Inc. 329.18 Million USD 77.877%
Clene Inc. 52.34 Million USD -39.136%
Capricor Therapeutics, Inc. 58.73 Million USD -23.991%
Boundless Bio, Inc. Common Stock 129.89 Million USD 43.935%
Recursion Pharmaceuticals, Inc. 653.69 Million USD 88.86%
Citius Pharmaceuticals, Inc. 103.61 Million USD 29.713%
Contineum Therapeutics, Inc. Class A Common Stock 130.38 Million USD 44.147%
Absci Corporation 234.48 Million USD 68.942%
Regeneron Pharmaceuticals, Inc. 33.08 Billion USD 99.78%
Surrozen, Inc. 46.08 Million USD -58.04%
Caribou Biosciences, Inc. 440.96 Million USD 83.485%
Janux Therapeutics, Inc. 380.4 Million USD 80.856%
Cingulate Inc. 3.49 Million USD -1985.818%
Galmed Pharmaceuticals Ltd. 16.62 Million USD -337.94%
Tenax Therapeutics, Inc. 11.68 Million USD -523.255%
Jaguar Health, Inc. 50.76 Million USD -43.461%
Terns Pharmaceuticals, Inc. 268.51 Million USD 72.879%
ACADIA Pharmaceuticals Inc. 748.95 Million USD 90.276%
Kronos Bio, Inc. 213.27 Million USD 65.855%
Innoviva, Inc. 1.24 Billion USD 94.144%
Bolt Biotherapeutics, Inc. 159.78 Million USD 54.423%
Entrada Therapeutics, Inc. 469.19 Million USD 84.479%
ZyVersa Therapeutics, Inc. 22.11 Million USD -229.312%
Soligenix, Inc. 9.79 Million USD -643.315%
AlloVir, Inc. 190.79 Million USD 61.831%
Century Therapeutics, Inc. 360.69 Million USD 79.81%
ORIC Pharmaceuticals, Inc. 254.68 Million USD 71.406%
Kura Oncology, Inc. 448.93 Million USD 83.778%
Ocean Biomedical, Inc. 110.91 Million USD 34.339%
Mineralys Therapeutics, Inc. 251.63 Million USD 71.059%
Eterna Therapeutics Inc. 49.13 Million USD -48.223%
SELLAS Life Sciences Group, Inc. 6.4 Million USD -1037.357%
Heron Therapeutics, Inc. 222.5 Million USD 67.271%
SAB Biotherapeutics, Inc. 83.94 Million USD 13.243%
Pasithea Therapeutics Corp. 26.11 Million USD -178.843%
Entero Therapeutics, Inc. 6.88 Million USD -958.012%
HCW Biologics Inc. 28.51 Million USD -155.404%
C4 Therapeutics, Inc. 376.45 Million USD 80.655%
Atara Biotherapeutics, Inc. 165.5 Million USD 55.998%
Coherus BioSciences, Inc. 629.6 Million USD 88.433%
Lantern Pharma Inc. 43.64 Million USD -66.848%
Histogen Inc. 19.07 Million USD -281.822%
Surrozen, Inc. 46.08 Million USD -58.04%
Eledon Pharmaceuticals, Inc. 125.89 Million USD 42.154%
Kodiak Sciences Inc. 479.37 Million USD 84.808%
MoonLake Immunotherapeutics 526.54 Million USD 86.169%
Hepion Pharmaceuticals, Inc. 18.09 Million USD -302.473%
Adverum Biotechnologies, Inc. 173.01 Million USD 57.907%
Avalo Therapeutics, Inc. 20.99 Million USD -246.901%
Moderna, Inc. 18.42 Billion USD 99.605%
Ionis Pharmaceuticals, Inc. 2.99 Billion USD 97.564%
Turnstone Biologics Corp. 112.81 Million USD 35.447%
Immix Biopharma, Inc. 19.92 Million USD -265.493%
Tiziana Life Sciences Ltd 12.18 Million USD -497.71%
Aurinia Pharmaceuticals Inc. 548.06 Million USD 86.712%
Exelixis, Inc. 2.94 Billion USD 97.525%
Monte Rosa Therapeutics, Inc. 303.75 Million USD 76.025%
Wave Life Sciences Ltd. 274.94 Million USD 73.513%
Conduit Pharmaceuticals Inc. 7.22 Million USD -908.098%
Alkermes plc 2.13 Billion USD 96.591%
Jasper Therapeutics, Inc. 95.38 Million USD 23.648%
Arcellx, Inc. 825.13 Million USD 91.174%
ESSA Pharma Inc. 149.12 Million USD 51.164%
TNF Pharmaceuticals, Inc. 17.86 Million USD -307.703%
Avid Bioservices, Inc. 336.55 Million USD 78.362%
Insmed Incorporated 1.32 Billion USD 94.524%
Cardiff Oncology, Inc. 81.63 Million USD 10.794%
Enanta Pharmaceuticals, Inc. 462.27 Million USD 84.246%
Moolec Science SA 24.05 Million USD -202.79%
RenovoRx, Inc. 1.46 Million USD -4867.599%
Acumen Pharmaceuticals, Inc. 310.12 Million USD 76.518%
Geron Corporation 394.07 Million USD 81.52%
LAVA Therapeutics N.V. 101.71 Million USD 28.399%
Verrica Pharmaceuticals Inc. 81.59 Million USD 10.75%
Royalty Pharma plc 16.38 Billion USD 99.555%
OmniAb, Inc. 401.98 Million USD 81.884%
Alector, Inc. 621.82 Million USD 88.289%
Atea Pharmaceuticals, Inc. 594.96 Million USD 87.76%
Mersana Therapeutics, Inc. 226.06 Million USD 67.785%
Humacyte, Inc. 128.22 Million USD 43.204%
Structure Therapeutics Inc. 482.01 Million USD 84.892%
Revance Therapeutics, Inc. 478.45 Million USD 84.779%
89bio, Inc. 596.26 Million USD 87.787%
Avenue Therapeutics, Inc. 1.85 Million USD -3836.486%
Aura Biosciences, Inc. 255.07 Million USD 71.45%
Immunic, Inc. 54.29 Million USD -34.118%
Veracyte, Inc. 1.13 Billion USD 93.6%
Genelux Corporation 27.89 Million USD -161.087%
Trevi Therapeutics, Inc. 89.4 Million USD 18.543%
Adial Pharmaceuticals, Inc. 4.73 Million USD -1437.494%
Sonnet BioTherapeutics Holdings, Inc. 5.42 Million USD -1241.289%
Immunovant, Inc. 666.71 Million USD 89.077%
Vericel Corporation 353.65 Million USD 79.408%
Fortrea Holdings Inc. 4.35 Billion USD 98.329%
KalVista Pharmaceuticals, Inc. 235.4 Million USD 69.064%
XBiotech Inc. 227.24 Million USD 67.953%
Agenus Inc. 313.91 Million USD 76.801%
Acasti Pharma Inc. 73.3 Million USD 0.648%
Kiora Pharmaceuticals, Inc. 13.71 Million USD -431.109%
MiNK Therapeutics, Inc. 4.55 Million USD -1499.747%
Pasithea Therapeutics Corp. 26.11 Million USD -178.843%
Theravance Biopharma, Inc. 381.99 Million USD 80.936%
Metagenomi, Inc. Common Stock 364.84 Million USD 80.039%
NeuroBo Pharmaceuticals, Inc. 22.78 Million USD -219.674%
Gain Therapeutics, Inc. 18.6 Million USD -291.336%
Tempest Therapeutics, Inc. 51.6 Million USD -41.126%
Sol-Gel Technologies Ltd. 45.28 Million USD -60.808%
Rhythm Pharmaceuticals, Inc. 332.74 Million USD 78.114%
United Therapeutics Corporation 7.16 Billion USD 98.984%
Creative Medical Technology Holdings, Inc. 10.71 Million USD -579.643%
BriaCell Therapeutics Corp. 5.87 Million USD -1140.153%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -1590.216%
Silo Pharma, Inc. 7.74 Million USD -840.146%
Telomir Pharmaceuticals, Inc. Common Stock 4.77 Million USD -1425.524%
Pharming Group N.V. 462.85 Million USD 84.266%
XOMA Corporation 234.3 Million USD 68.918%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD -284.835%
Bionomics Limited 27.64 Million USD -163.39%
Alpha Tau Medical Ltd. 107.38 Million USD 32.185%
Pyxis Oncology, Inc. 173.72 Million USD 58.081%
uniQure N.V. 831.68 Million USD 91.244%
Xilio Therapeutics, Inc. 60.92 Million USD -19.53%
Cassava Sciences, Inc. 151.66 Million USD 51.982%
60 Degrees Pharmaceuticals, Inc. 7.78 Million USD -835.6%
Windtree Therapeutics, Inc. 32.4 Million USD -124.727%
Poseida Therapeutics, Inc. 273.88 Million USD 73.41%
Pluri Inc. 39.52 Million USD -84.241%
Anebulo Pharmaceuticals, Inc. 4.07 Million USD -1687.944%
MeiraGTx Holdings plc 458.16 Million USD 84.105%
Cidara Therapeutics, Inc. 68.53 Million USD -6.267%
ProMIS Neurosciences, Inc. 18.04 Million USD -303.575%
CalciMedica, Inc. 12.18 Million USD -497.661%
Sana Biotechnology, Inc. 565.29 Million USD 87.117%
Amicus Therapeutics, Inc. 777.88 Million USD 90.638%
Salarius Pharmaceuticals, Inc. 6.58 Million USD -1005.667%
Alpha Tau Medical Ltd. 107.38 Million USD 32.185%
Adlai Nortye Ltd. American Depositary Shares 130.18 Million USD 44.062%
Nutriband Inc. 7.51 Million USD -868.784%
Protara Therapeutics, Inc. 78.95 Million USD 7.763%
Compugen Ltd. 121.33 Million USD 39.98%
Roivant Sciences Ltd. 7.22 Billion USD 98.992%
ProKidney Corp. 420.55 Million USD 82.683%
Protagenic Therapeutics, Inc. 4.32 Million USD -1584.45%
Elevai Labs, Inc. Common Stock 5.18 Million USD -1303.201%
Tango Therapeutics, Inc. 402.56 Million USD 81.91%
Renovaro Biosciences Inc. 163.12 Million USD 55.358%
Zevra Therapeutics, Inc. 172.32 Million USD 57.74%
Benitec Biopharma Inc. 52.21 Million USD -39.485%
GeoVax Labs, Inc. 9.28 Million USD -684.48%
Biomea Fusion, Inc. 199.92 Million USD 63.574%
Cullinan Oncology, Inc. 485.09 Million USD 84.988%
4D Molecular Therapeutics, Inc. 339.89 Million USD 78.574%
Kiniksa Pharmaceuticals, Ltd. 526.32 Million USD 86.163%
Nuvectis Pharma, Inc. 19.18 Million USD -279.593%
Spyre Therapeutics, Inc. 341.85 Million USD 78.697%
Ventyx Biosciences, Inc. 277.69 Million USD 73.775%
Imunon, Inc. 21.91 Million USD -232.26%
BioAtla, Inc. 119.65 Million USD 39.139%
Allogene Therapeutics, Inc. 642.83 Million USD 88.671%
Larimar Therapeutics, Inc. 95.93 Million USD 24.089%
Zura Bio Limited 100.84 Million USD 27.784%
aTyr Pharma, Inc. 122.06 Million USD 40.34%
Madrigal Pharmaceuticals, Inc. 640.54 Million USD 88.631%
Viridian Therapeutics, Inc. 490.42 Million USD 85.151%
Galecto, Inc. 38.22 Million USD -90.507%
Tevogen Bio Holdings Inc. 17.03 Million USD -327.444%
Halozyme Therapeutics, Inc. 1.73 Billion USD 95.798%
Lexicon Pharmaceuticals, Inc. 229.42 Million USD 68.258%
PolyPid Ltd. 15.37 Million USD -373.751%
Aileron Therapeutics, Inc. 119.28 Million USD 38.949%
Forte Biosciences, Inc. 38.98 Million USD -86.827%
Xencor, Inc. 952.69 Million USD 92.356%
Coeptis Therapeutics Holdings, Inc. 8.07 Million USD -802.295%
Lexaria Bioscience Corp. 3.08 Million USD -2261.392%
Instil Bio, Inc. 325.63 Million USD 77.636%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -1531.982%
OncoCyte Corporation 74.89 Million USD 2.76%
Elevation Oncology, Inc. 89.09 Million USD 18.258%
Purple Biotech Ltd. 44.3 Million USD -64.383%
CollPlant Biotechnologies Ltd. 34.12 Million USD -113.4%
MacroGenics, Inc. 306.82 Million USD 76.265%
Verona Pharma plc 308.12 Million USD 76.365%
Tharimmune, Inc. 10.94 Million USD -565.288%
Apogee Therapeutics, Inc. 401.4 Million USD 81.857%
enGene Holdings Inc. Warrants 86.95 Million USD 16.254%
Aditxt, Inc. 44.57 Million USD -63.364%
XTL Biopharmaceuticals Ltd. 2.42 Million USD -2901.855%
Savara Inc. 177.56 Million USD 58.987%
Curis, Inc. 77.28 Million USD 5.767%
Carmell Therapeutics Corporation 63.94 Million USD -13.88%
Achieve Life Sciences, Inc. 19.37 Million USD -275.949%
BeiGene, Ltd. 5.8 Billion USD 98.746%
Protagenic Therapeutics, Inc. 4.32 Million USD -1584.45%
Vincerx Pharma, Inc. 18.21 Million USD -299.764%
Plus Therapeutics, Inc. 11.38 Million USD -539.489%
Acrivon Therapeutics, Inc. Common Stock 138.26 Million USD 47.329%
Rigel Pharmaceuticals, Inc. 117.22 Million USD 37.876%
Adicet Bio, Inc. 207.29 Million USD 64.869%
Estrella Immunopharma, Inc. 4.45 Million USD -1534.978%
Quantum-Si incorporated 298.25 Million USD 75.583%
Acurx Pharmaceuticals, Inc. 7.7 Million USD -844.66%
Generation Bio Co. 374.75 Million USD 80.567%
Black Diamond Therapeutics, Inc. 158.56 Million USD 54.073%
Invivyd, Inc. 229.18 Million USD 68.224%
Relay Therapeutics, Inc. 843.98 Million USD 91.371%
Quoin Pharmaceuticals, Ltd. 12.16 Million USD -498.432%
Moolec Science SA 24.05 Million USD -202.79%
Clearside Biomedical, Inc. 34.01 Million USD -114.078%
Longboard Pharmaceuticals, Inc. 50.69 Million USD -43.648%
Relmada Therapeutics, Inc. 97.55 Million USD 25.348%
ALX Oncology Holdings Inc. 242.55 Million USD 69.976%
Vir Biotechnology, Inc. 1.96 Billion USD 96.285%
Evaxion Biotech A/S 12.88 Million USD -465.033%
Ocular Therapeutix, Inc. 252.06 Million USD 71.108%
Tyra Biosciences, Inc. 225.85 Million USD 67.756%
Unity Biotechnology, Inc. 65.69 Million USD -10.862%
Connect Biopharma Holdings Limited 125.89 Million USD 42.153%
Clearmind Medicine Inc. 4.32 Million USD -1584.053%
Aadi Bioscience, Inc. 132.42 Million USD 45.006%
Catalyst Pharmaceuticals, Inc. 471.9 Million USD 84.568%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -750.699%
Viking Therapeutics, Inc. 368.49 Million USD 80.237%
Keros Therapeutics, Inc. 370.02 Million USD 80.319%
Crinetics Pharmaceuticals, Inc. 635.35 Million USD 88.538%
ImmunityBio, Inc. 504.45 Million USD 85.564%
Korro Bio, Inc. 221.66 Million USD 67.146%
Kineta, Inc. 10.28 Million USD -608.345%
BioVie Inc. 25.2 Million USD -188.892%
Codexis, Inc. 136.56 Million USD 46.672%
Celularity Inc. 143.88 Million USD 49.388%
Virax Biolabs Group Limited 5.48 Million USD -1227.962%
Cibus, Inc. 544.41 Million USD 86.623%
Annexon, Inc. 297.67 Million USD 75.535%
Assembly Biosciences, Inc. 137.46 Million USD 47.024%
Eyenovia, Inc. 28.77 Million USD -153.046%
Puma Biotechnology, Inc. 230.52 Million USD 68.409%
NeurAxis, Inc. 509.49 Thousand USD -14193.481%
Regulus Therapeutics Inc. 30.75 Million USD -136.829%
Compass Therapeutics, Inc. 156.87 Million USD 53.578%
TFF Pharmaceuticals, Inc. 12.02 Million USD -505.497%
Notable Labs, Ltd. 19.54 Million USD -272.678%
IN8bio, Inc. 33.7 Million USD -116.04%
DiaMedica Therapeutics Inc. 54.16 Million USD -34.463%
Vera Therapeutics, Inc. 175.54 Million USD 58.515%
Lumos Pharma, Inc. 40.63 Million USD -79.204%
Liquidia Corporation 120.43 Million USD 39.53%
Mustang Bio, Inc. 17.74 Million USD -310.467%
Quantum-Si incorporated 298.25 Million USD 75.583%
Arbutus Biopharma Corporation 144.4 Million USD 49.568%
enGene Holdings Inc. Common Stock 86.95 Million USD 16.254%
ARS Pharmaceuticals, Inc. 233.18 Million USD 68.77%
180 Life Sciences Corp. 5.25 Million USD -1284.644%
Vaxcyte, Inc. 1.4 Billion USD 94.827%
Xenon Pharmaceuticals Inc. 964.79 Million USD 92.452%
Estrella Immunopharma, Inc. 4.45 Million USD -1534.978%
NKGen Biotech, Inc. Warrants 34.77 Million USD -109.43%
Opiant Pharmaceuticals, Inc. 70.42 Million USD -3.404%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -750.699%
Soleno Therapeutics, Inc. 180.69 Million USD 59.696%
PepGen Inc. 143.05 Million USD 49.092%
Moleculin Biotech, Inc. 38.21 Million USD -90.557%
Solid Biosciences Inc. 164.93 Million USD 55.847%
Palisade Bio, Inc. 14.05 Million USD -418.254%
Nutriband Inc. 7.51 Million USD -868.784%
Conduit Pharmaceuticals Inc. 7.22 Million USD -908.098%
Immuneering Corporation 102.58 Million USD 29.01%
Belite Bio, Inc 94.64 Million USD 23.052%
CG Oncology, Inc. Common stock 199.3 Million USD 63.46%
GeoVax Labs, Inc. 9.28 Million USD -684.48%
Tourmaline Bio, Inc. 210.29 Million USD 65.37%
Altimmune, Inc. 210.64 Million USD 65.427%
Peak Bio, Inc. 2.59 Million USD -2704.829%
SeaStar Medical Holding Corporation 3.51 Million USD -1973.015%
FibroBiologics, Inc. Common Stock 11.82 Million USD -516.065%
Neurogene Inc. 222.57 Million USD 67.28%
Mirum Pharmaceuticals, Inc. 646.62 Million USD 88.738%
Kintara Therapeutics, Inc. 6.2 Million USD -1074.218%
CARGO Therapeutics, Inc. Common Stock 453.03 Million USD 83.925%
Sesen Bio, Inc. 189.17 Million USD 61.504%
argenx SE 4.54 Billion USD 98.397%
NKGen Biotech, Inc. Common Stock 34.77 Million USD -109.43%
Dianthus Therapeutics, Inc. 179.4 Million USD 59.407%
Immunome, Inc. 148.54 Million USD 50.973%
Enveric Biosciences, Inc. 6.11 Million USD -1090.441%
Design Therapeutics, Inc. 289.64 Million USD 74.857%
Seelos Therapeutics, Inc. 5.41 Million USD -1244.131%
Enliven Therapeutics, Inc. 271.86 Million USD 73.213%
Iovance Biotherapeutics, Inc. 780.35 Million USD 90.668%
Taysha Gene Therapies, Inc. 266.99 Million USD 72.724%
Inovio Pharmaceuticals, Inc. 172.94 Million USD 57.891%
Athira Pharma, Inc. 160.24 Million USD 54.554%
XOMA Corporation 234.3 Million USD 68.918%
Merus N.V. 458.49 Million USD 84.116%
Quince Therapeutics, Inc. 180.2 Million USD 59.587%
Rezolute, Inc. 132.73 Million USD 45.136%
Clene Inc. 52.34 Million USD -39.136%
Indaptus Therapeutics, Inc. 14.92 Million USD -387.976%
BeyondSpring Inc. 24.8 Million USD -193.554%
Synlogic, Inc. 75.55 Million USD 3.607%
Allarity Therapeutics, Inc. 11.86 Million USD -513.935%
Phio Pharmaceuticals Corp. 9.36 Million USD -677.713%
Peak Bio, Inc. 2.59 Million USD -2704.829%
Werewolf Therapeutics, Inc. 174.83 Million USD 58.346%
Krystal Biotech, Inc. 818.35 Million USD 91.101%
Karyopharm Therapeutics Inc. 240.43 Million USD 69.712%
SpringWorks Therapeutics, Inc. 725.78 Million USD 89.966%
Lipella Pharmaceuticals Inc. 3.57 Million USD -1935.825%
MannKind Corporation 475.19 Million USD 84.675%
Ikena Oncology, Inc. 192.09 Million USD 62.088%
Cyclerion Therapeutics, Inc. 13.37 Million USD -444.527%
Gyre Therapeutics, Inc. 116.53 Million USD 37.51%
Gossamer Bio, Inc. 311.91 Million USD 76.652%
CohBar, Inc. 16.36 Million USD -344.986%
Cognition Therapeutics, Inc. 35.16 Million USD -107.107%
NRx Pharmaceuticals, Inc. 7.31 Million USD -895.557%
Legend Biotech Corporation 1.84 Billion USD 96.061%
Mural Oncology plc 301.74 Million USD 75.865%
Disc Medicine, Inc. 367.99 Million USD 80.21%
Champions Oncology, Inc. 26.13 Million USD -178.681%
REGENXBIO Inc. 573.97 Million USD 87.312%
Ensysce Biosciences, Inc. 2.7 Million USD -2589.17%
Anavex Life Sciences Corp. 154.38 Million USD 52.829%
Cellectar Biosciences, Inc. 12.07 Million USD -503.077%
Edgewise Therapeutics, Inc. 340.03 Million USD 78.583%
Vaxart, Inc. 91.83 Million USD 20.696%
PharmaCyte Biotech, Inc. 59.9 Million USD -21.57%
Aldeyra Therapeutics, Inc. 148.32 Million USD 50.902%
Cellectis S.A. 334.27 Million USD 78.214%
Longeveron Inc. 12.17 Million USD -498.005%
Repare Therapeutics Inc. 253.9 Million USD 71.318%
Sarepta Therapeutics, Inc. 3.26 Billion USD 97.769%
Inozyme Pharma, Inc. 200.84 Million USD 63.741%
Revolution Medicines, Inc. 2.08 Billion USD 96.513%
Nymox Pharmaceutical Corporation 1.62 Million USD -4381.538%
Third Harmonic Bio, Inc. 277.71 Million USD 73.777%
ArriVent BioPharma, Inc. Common Stock 163.09 Million USD 55.349%
AN2 Therapeutics, Inc. 138.74 Million USD 47.511%
Anixa Biosciences, Inc. 25.52 Million USD -185.342%
Vertex Pharmaceuticals Incorporated 22.73 Billion USD 99.68%
Denali Therapeutics Inc. 1.15 Billion USD 93.689%
Revelation Biosciences, Inc. 12.21 Million USD -496.31%
Veru Inc. 50.59 Million USD -43.935%
Corvus Pharmaceuticals, Inc. 45.55 Million USD -59.869%
Cingulate Inc. 3.49 Million USD -1985.818%
Passage Bio, Inc. 150.54 Million USD 51.626%
Context Therapeutics Inc. 16.06 Million USD -353.379%
Exicure, Inc. 11.58 Million USD -528.886%
Day One Biopharmaceuticals, Inc. 376.04 Million USD 80.634%
Oramed Pharmaceuticals Inc. 161.64 Million USD 54.947%
Scinai Immunotherapeutics Ltd. 17.47 Million USD -316.81%
Nuvalent, Inc. 732.38 Million USD 90.056%
ABVC BioPharma, Inc. 14.94 Million USD -387.317%
Carisma Therapeutics, Inc. 89.55 Million USD 18.68%
Unicycive Therapeutics, Inc. 14.19 Million USD -413.177%
OmniAb, Inc. 401.98 Million USD 81.884%
Anew Medical, Inc. 19.45 Million USD -274.307%
Fennec Pharmaceuticals Inc. 26.72 Million USD -172.482%
Lipocine Inc. 23 Million USD -216.616%
Lexeo Therapeutics, Inc. Common Stock 139.8 Million USD 47.91%
Nautilus Biotechnology, Inc. 305.56 Million USD 76.167%
SAB Biotherapeutics, Inc. 83.94 Million USD 13.243%
G1 Therapeutics, Inc. 121.54 Million USD 40.081%
Bellerophon Therapeutics, Inc. 7.93 Million USD -817.769%
Sage Therapeutics, Inc. 882.27 Million USD 91.746%
Ocugen, Inc. 64.54 Million USD -12.825%
Mind Medicine (MindMed) Inc. 124.54 Million USD 41.525%
Q32 Bio Inc. 306.11 Million USD 76.21%
Brainstorm Cell Therapeutics Inc. 4.2 Million USD -1630.632%
Alumis Inc. Common Stock 89.61 Million USD 18.733%
Equillium, Inc. 50.53 Million USD -44.122%
Kyverna Therapeutics, Inc. 75.19 Million USD 3.152%
Coya Therapeutics, Inc. 41.27 Million USD -76.445%
CNS Pharmaceuticals, Inc. 1.7 Million USD -4181.675%
Dominari Holdings Inc. 57.55 Million USD -26.525%
Edesa Biotech, Inc. 8.89 Million USD -719.139%
vTv Therapeutics Inc. 11.01 Million USD -560.964%
Bio-Techne Corporation 2.81 Billion USD 97.411%
Agios Pharmaceuticals, Inc. 937.11 Million USD 92.229%
Harmony Biosciences Holdings, Inc. 811.44 Million USD 91.025%
Prelude Therapeutics Incorporated 277.66 Million USD 73.772%
Candel Therapeutics, Inc. 41.7 Million USD -74.632%
iTeos Therapeutics, Inc. 667.58 Million USD 89.091%
Nkarta, Inc. 378.88 Million USD 80.779%
BioCardia, Inc. 2.98 Million USD -2338.065%
Iterum Therapeutics plc 26.25 Million USD -177.333%